C

FSN

214270KOSDAQ소프트웨어 개발 및 공급업

50.8 / 100

Reference Date: 2026-06-10

Financial Score15.5 / 40
News Sentiment21.3 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Plunged 32.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

FSN operates in two main business segments: digital marketing services and brand/platform operations. The company provides comprehensive one-stop marketing solutions, achieving an advertising handling volume of 5.693 trillion KRW in 2024 and maintaining a strong market position through numerous awards in key marketing events. It enhances its integrated marketing capabilities through a diverse portfolio of subsidiaries. Additionally, the company drives sustained growth through brand partnership initiatives and the expansion of its own platforms.

Number of Employees

114people

Average Salary

60.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 13.624.0Point
PBR
0.62Industry Average 1.025.5Point

Lower than industry avg (good)

ROE
-16.68Industry Average 1.100.0Point

Well below industry avg

Debt Ratio
47.39Industry Average 7.930.0Point

6.0x industry avg (risky)

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲26.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲1842.1% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -33.9% (improving, 3yr)

Detailed News Sentiment

7 totalPositive 7Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 1,293Won52-week high 3,56052-week low 1,293
1-month return0.0Point

1m -32.62% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-09
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-09
  • Neutral주식등의대량보유상황보고서(일반)2026-06-09
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-09
  • Neutral주식등의대량보유상황보고서(일반)2026-05-15